Bosko Andjelic

539 total citations
37 papers, 359 citations indexed

About

Bosko Andjelic is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Bosko Andjelic has authored 37 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 10 papers in Genetics. Recurrent topics in Bosko Andjelic's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (12 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Bosko Andjelic is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (12 papers) and CNS Lymphoma Diagnosis and Treatment (10 papers). Bosko Andjelic collaborates with scholars based in Serbia, United Kingdom and Denmark. Bosko Andjelic's co-authors include Biljana Mihaljević, Milena Todorović, Darko Antić, Jelena Bila, Jelena Jelicic, Andrija Bogdanović, Vojin Vuković, Vladimir Bumbaširević, Bela Balint and Nataša Milić and has published in prestigious journals such as International Journal of Molecular Sciences, Annals of Oncology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Bosko Andjelic

37 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bosko Andjelic Serbia 12 244 140 87 83 61 37 359
Greg Hapgood Australia 9 226 0.9× 123 0.9× 38 0.4× 51 0.6× 55 0.9× 28 390
Sudha Parasuraman United States 8 78 0.3× 102 0.7× 69 0.8× 37 0.4× 25 0.4× 15 304
A. Franke Germany 11 103 0.4× 107 0.8× 117 1.3× 29 0.3× 29 0.5× 28 362
Donato Mannina Italy 9 193 0.8× 80 0.6× 56 0.6× 76 0.9× 11 0.2× 24 292
Tzung‐Chih Tang Taiwan 14 197 0.8× 146 1.0× 111 1.3× 68 0.8× 47 0.8× 33 507
Granada Perea Spain 8 91 0.4× 74 0.5× 51 0.6× 29 0.3× 12 0.2× 12 278
JR Schriber United States 8 86 0.4× 212 1.5× 102 1.2× 62 0.7× 108 1.8× 9 528
María Teresa Santarelli Argentina 9 141 0.6× 57 0.4× 43 0.5× 46 0.6× 19 0.3× 17 431
Philip Bennett United Kingdom 9 48 0.2× 51 0.4× 40 0.5× 18 0.2× 44 0.7× 22 339
Masayuki Yamakura Japan 13 298 1.2× 152 1.1× 134 1.5× 283 3.4× 22 0.4× 23 577

Countries citing papers authored by Bosko Andjelic

Since Specialization
Citations

This map shows the geographic impact of Bosko Andjelic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bosko Andjelic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bosko Andjelic more than expected).

Fields of papers citing papers by Bosko Andjelic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bosko Andjelic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bosko Andjelic. The network helps show where Bosko Andjelic may publish in the future.

Co-authorship network of co-authors of Bosko Andjelic

This figure shows the co-authorship network connecting the top 25 collaborators of Bosko Andjelic. A scholar is included among the top collaborators of Bosko Andjelic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bosko Andjelic. Bosko Andjelic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jelicic, Jelena, et al.. (2024). Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review. Critical Reviews in Oncology/Hematology. 196. 104293–104293. 2 indexed citations
2.
Jelicic, Jelena, et al.. (2021). Prognostic models in primary central nervous system lymphoma patients: A systematic review. Critical Reviews in Oncology/Hematology. 161. 103341–103341. 4 indexed citations
3.
Jelicic, Jelena, Thomas Stauffer Larsen, Zoran Bukumirić, & Bosko Andjelic. (2021). The clinical applicability of current prognostic models in follicular lymphoma: A systematic review. Critical Reviews in Oncology/Hematology. 164. 103418–103418. 5 indexed citations
4.
Marković, Olivera, Bosko Andjelic, Milena Todorović, et al.. (2019). Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome?. PubMed. 22(2). 481–486. 2 indexed citations
5.
Mihaljević, Biljana, Sandra Šipetić Grujičić, Svetlana Ignjatović, et al.. (2018). 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it?. Supportive Care in Cancer. 26(8). 2825–2832. 10 indexed citations
6.
Mihaljević, Biljana, Jelena Jelicic, Bosko Andjelic, et al.. (2016). FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma. International Journal of Hematology. 104(6). 692–699. 7 indexed citations
7.
Antić, Darko, Nataša Milić, Milena Todorović, et al.. (2016). OC-07 - Decoding risk for thromboembolic events in lymphoma patients. Thrombosis Research. 140. S171–S171. 2 indexed citations
8.
9.
Jelicic, Jelena, Milena Todorović, Novica Boričić, et al.. (2016). The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas. Pathology & Oncology Research. 22(3). 567–577. 8 indexed citations
10.
Andjelic, Bosko, et al.. (2015). Follicular lymphoma patients with a high FLIPI score and a high tumor burden: A risk stratification model. Vojnosanitetski pregled. 72(1). 26–32. 2 indexed citations
11.
12.
Jelicic, Jelena, Milena Todorović, Rosanda Ilić, et al.. (2015). The possible benefit from total tumour resection in primary diffuse large B-cell lymphoma of central nervous system – a one-decade single-centre experience. British Journal of Neurosurgery. 30(1). 80–85. 23 indexed citations
13.
Bila, Jelena, Jelena Jelicic, Vojin Vuković, et al.. (2015). Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 15(7). 416–419. 25 indexed citations
14.
Todorović, Milica, Bela Balint, Bosko Andjelic, & Biljana Mihaljević. (2014). Multiple malignancies in a female patient with common variable immunodeficiency syndrome. Singapore Medical Journal. 55(10). e162–e164. 2 indexed citations
15.
Bila, Jelena, et al.. (2013). Extramedullary plasmacytoma of the tongue base: A rare presentation of head and neck plasmacytoma. Vojnosanitetski pregled. 70(10). 972–975. 2 indexed citations
16.
17.
Todorović, Milena, Ziv Radisavljevic, Bela Balint, et al.. (2012). Increased Angiogenesis-associated Poor Outcome in Acute Lymphoblastic Leukemia. Applied immunohistochemistry & molecular morphology. 20(5). 488–493. 11 indexed citations
18.
Mihaljević, Biljana, et al.. (2011). The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma. Leukemia & lymphoma. 52(10). 1913–1919. 41 indexed citations
19.
Trifunović, Danijela, Miodrag Ostojić, Arsen Ristić, et al.. (2010). Multimodality Imaging in the Assessment of Cardiac Lymphoma Presented as New‐Onset Atrial Fibrillation. Echocardiography. 27(3). 332–336. 4 indexed citations
20.
Mihaljević, Biljana, et al.. (2008). Mediastinal lymphomas: Differential diagnosis. Vojnosanitetski pregled. 65(2). 167–170. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Greg Hapgood Breakdown of academic impact, for papers by Sudha Parasuraman Breakdown of academic impact, for papers by A. Franke Breakdown of academic impact, for papers by Donato Mannina Breakdown of academic impact, for papers by Tzung‐Chih Tang Breakdown of academic impact, for papers by Granada Perea Breakdown of academic impact, for papers by JR Schriber Breakdown of academic impact, for papers by María Teresa Santarelli Breakdown of academic impact, for papers by Philip Bennett Breakdown of academic impact, for papers by Masayuki Yamakura
Rankless by CCL
2026